Literature DB >> 15885566

Decision support of inspired oxygen selection based on Bayesian learning of pulmonary gas exchange parameters.

David Murley1, Stephen Rees, Bodil Rasmussen, Steen Andreassen.   

Abstract

OBJECTIVE: To investigate if the real-time Bayesian learning of physiological model parameters can be used to support and improve the selection of inspired oxygen fraction. METHODS AND MATERIAL: Supporting the selection of inspired oxygen fraction relies on predictions of arterial oxygen saturation. The efficacy of using these predictions to select inspired oxygen was tested retrospectively in a system for estimating gas exchange parameters of the lung (Automatic Lung Parameter Estimator, ALPE). For the predictions to offer effective decision support they need to be accurate and above all safe. These qualities were tested with data from 16 post-operative cardiac patients, using two different tests. The aim of the first test was to assess retrospectively if the predictions could have supported clinical decisions. The second test sought to establish if the predictions could support improving the efficiency of inspired oxygen selection during an ALPE oxygen titration.
RESULTS: The predictions were found to be reasonably accurate, and most importantly safe in both of the tests.
CONCLUSION: The method described can be used to support the selection of inspired oxygen fraction, and it has the potential to improve the efficiency of inspired oxygen selection during an oxygen titration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885566     DOI: 10.1016/j.artmed.2004.07.012

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  1 in total

1.  Clinical refinement of the automatic lung parameter estimator (ALPE).

Authors:  Lars P Thomsen; Dan S Karbing; Bram W Smith; David Murley; Ulla M Weinreich; Søren Kjærgaard; Egon Toft; Per Thorgaard; Steen Andreassen; Stephen E Rees
Journal:  J Clin Monit Comput       Date:  2013-02-21       Impact factor: 2.502

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.